Response to Comments: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules

This document (A59734) is a Response to Comments regarding the MolDX Local Coverage Determination L39646 for molecular testing of thyroid nodules; it records the comment period (8/31/2023–10/14/2023), notice start (6/13/2024), and effective date (7/28/2024). It does not contain the LCD's clinical coverage criteria—consult LCD L39646 for specific indications, limitations, documentation, and frequency rules. Extraction of actionable coverage criteria requires review of L39646.

"This document is a 'Response to Comments' for MolDX LCD L39646 and records the comment period (2023-08-31 to 2023-10-14), notice start (2024-06-13), and effective date (2024-07-28); it does not its..."

Sign up to see full coverage criteria, indications, and limitations.